ArticleClinical rheumatology2022

Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.

Hatice Bodur et al.PubMed ↗Publisher ↗

No numbers read from the abstract.